Differences
This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
treatment_sodium_bicarbonate [2025/04/13 01:49] – [6.3 Pharmaceutics] jkohts | treatment_sodium_bicarbonate [2025/04/16 04:26] (current) – [2.2 Salicylate Toxicity] jkohts | ||
---|---|---|---|
Line 2: | Line 2: | ||
===== - Overview ===== | ===== - Overview ===== | ||
+ | Sodium bicarbonate (NaHCO₃) is primarily used in toxicology to treat sodium channel blocker toxicity (e.g. TCA toxicity). | ||
- | + | The patient should then be [[concept_serum_alkalinization|hyperventilated]]. | |
- | Sodium Bicarbonate (NaHCO3) is the primary antidote for [[: | + | |
- | + | ||
- | The patient should then be [[: | + | |
Line 33: | Line 31: | ||
* 💊👶 **Sodium bicarbonate 1-2 mmol/kg IV** (i.e. 1-2 mL/kg of 8.4% NaHCO3), as initial dose, then start infusion. | * 💊👶 **Sodium bicarbonate 1-2 mmol/kg IV** (i.e. 1-2 mL/kg of 8.4% NaHCO3), as initial dose, then start infusion. | ||
* 💊👶 **Sodium bicarbonate 1.5-2× patient' | * 💊👶 **Sodium bicarbonate 1.5-2× patient' | ||
- | * Maintain normokalemia. | ||
* Goals: | * Goals: | ||
* Serum pH 7.5-7.55. | * Serum pH 7.5-7.55. | ||
* Urinary pH >7.5. | * Urinary pH >7.5. | ||
* Urine output 2-3 mL/kg/hr. | * Urine output 2-3 mL/kg/hr. | ||
+ | * Maintain normokalemia. | ||
Line 53: | Line 50: | ||
===== - Special Populations ===== | ===== - Special Populations ===== | ||
- | **Renal impairment: | + | **Renal impairment: |
- | + | ||
- | **Hepatic | + | |